Kodiak Sciences Inc.(KOD)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
KOD Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Kodiak Sciences Inc. (KOD), a Healthcare sector company. KOD is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q2 2026), Kodiak Sciences Inc. reports net income of $-65.6M, free cash flow of $-46.6M. Top institutional holders of KOD by reported 13-F value include BAKER BROS. ADVISORS, BlackRock, PRICE T ROWE ASSOCIATES, based on the most recent SEC filings. KOD trades on the Nasdaq exchange and files with the SEC under CIK 1468748. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KOD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Kodiak Sciences Inc. directly from SEC EDGAR.
Net Income
Q2 2026
$-65.6M
Free Cash Flow
Q2 2026
$-46.6M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
-30.5% YoYOperating Income
-25.4% YoYEPS (Diluted)
-29.0% YoYTotal Assets
+4.8% YoYOp. Cash Flow
-15.9% YoYFree Cash Flow
-16.0% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-230.0M -30.5% | $-176.2M +32.4% | $-260.5M +22.0% | $-333.8M -25.0% | $-267.0M -100.6% | $-133.1M |
| Operating Income | $-234.4M -25.4% | $-186.8M +32.6% | $-277.3M +18.8% | $-341.4M -27.8% | $-267.1M -96.4% | $-136.0M |
| EPS (Diluted) | $-4.32 -29.0% | $-3.35 +32.6% | $-4.97 +22.2% | $-6.39 -23.8% | $-5.16 -77.3% | $-2.91 |
| Total Assets | $351.5M +4.8% | $335.6M -30.0% | $479.4M -28.1% | $666.6M -26.3% | $904.2M -15.3% | $1.07B |
| Operating Cash Flow | $-136.0M -15.9% | $-117.3M +23.9% | $-154.2M +25.3% | $-206.5M -13.3% | $-182.3M -118.5% | $-83.4M |
| Free Cash Flow | $-136.5M -16.0% | $-117.7M +39.8% | $-195.5M +19.7% | $-243.5M -22.2% | $-199.3M -128.4% | $-87.2M |
Get alerted when KOD's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Kodiak Sciences Inc. including:
Top Institutional Holders of KOD
BAKER BROS. ADVISORS LP
$776.1M19,919,186 shBlackRock, Inc.
$161.1M4,135,355 shPRICE T ROWE ASSOCIATES INC /MD/
$126.6M3,248,611 shSTATE STREET CORP
$94.3M2,419,417 shGOLDMAN SACHS GROUP INC
$90.2M2,316,014 shVANGUARD CAPITAL MANAGEMENT LLC
$70.3M1,804,632 shBRAIDWELL LP
$69.6M1,787,318 shJupiter Topco LLC
$59.5M1,526,006 shRTW INVESTMENTS, LP
$58.0M1,487,934 shBoxer Capital Management, LLC
$57.6M1,477,600 sh
| Fund | Value | Shares |
|---|---|---|
| BAKER BROS. ADVISORS LP | $776.1M | 19,919,186 |
| BlackRock, Inc. | $161.1M | 4,135,355 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $126.6M | 3,248,611 |
| STATE STREET CORP | $94.3M | 2,419,417 |
| GOLDMAN SACHS GROUP INC | $90.2M | 2,316,014 |
| VANGUARD CAPITAL MANAGEMENT LLC | $70.3M | 1,804,632 |
| BRAIDWELL LP | $69.6M | 1,787,318 |
| Jupiter Topco LLC | $59.5M | 1,526,006 |
| RTW INVESTMENTS, LP | $58.0M | 1,487,934 |
| Boxer Capital Management, LLC | $57.6M | 1,477,600 |
More Healthcare Companies
View all Healthcare →Put KOD on your watchlist
Track score changes the day Kodiak Sciences Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is KOD a good stock to buy?
13F Pro's AI-powered analysis of Kodiak Sciences Inc. (KOD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for KOD are available on the KOD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. KOD is classified as a mid company.
Which hedge funds own KOD?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling KOD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Kodiak Sciences Inc.'s investment landscape.